Replies to post #85864 on Decision Diagnostics Corp (DECN)

[IPwatcher]

131 companies have been granted EUA by the FDA
In a matter of a couple of months?
That is rather a lot don't you think?
The FDA are setting the bar as low as they can.
And yet - according to their own reluctant and belated admission, DECN have faceplanted into it twice already! That is not a good look!
And - if we are take Berman's word for it - one of them was even before the FDA tightened things up because of all the rubbish tests that they were letting slip through!?

I need to check but I believe that I saw somewhere that about 65% of submitted EUA applications were getting approved. It may have been in a televised Q&A or something.
(I will look for confirmation of this... I remember seeing it but haven't been able to check teh source yet, so it may be wrong! If I am wrong on that point I will apologise in advance if i have misremembered. I will try and unearth the real actual statistic. If anyone else has it to hand along with supporting evidence feel free to assist!)

Anyhow the REAL question that everyone needs to be asking is WHY ARENT DECN'S SYSTEMS NUMBERED AMONG THE 131 THAT HEVE BEEN GRANTED EAU EXEMPTION ALREADY?

It is not a question I am asking myself. Because I already know the answer.
But it is a question that people should be asking of Berman and DECN.
And - if I might be also be so bold - I would suggest that it is a question that people should not take his answer at face value on, but instead demand VERIFIABLE evidence from him that he is not shooting a line as so often in the past!

The FDA will have advised DECN where the deficiencies in their purported DECN EUA submission lay (if indeed the purported completed EUA applications actually exist! I still maintain that DECN has probably amended INCOMPLETE EUA applications as there are requirements in those templates that DECN simply could not physically have complied with. By this I mean that DECN may have submitted EUA applications without all of the stipulated requirements therein in the misplaced hope that FDA woudl waive those requirements, e.g. the requirement to actually test a sample medium that actually shows up teh infection!).

Those FDA responses would make interesting reading w.r.t to explaining to concerned shareholders why DECN is not listed among the 131 already approved EUAs. I am sure alot of them are wondering.

And if DECN has nothing to hide there, it has nothing to fear by making those FDA responses public. If they even exist.
Because thus far, we have only the word of a proven liar on this!